4O04

Identification of novel HSP90/isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's disease


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.82 Å
  • R-Value Free: 0.205
  • R-Value Work: 0.191

Literature

Macromolecules
Sequence Display for 4O04

Classification: CHAPERONE / CHAPERONE INHIBITOR

Total Structure Weight: 26534.84

Macromolecule Entities
Molecule Chains Length Organism Details
Heat shock protein HSP 90-alpha A 233 Homo sapiens Fragment: UNP residues 9-236
Gene Name(s): HSP90AA1 Gene View HSP90A HSPC1 HSPCA
Metabolic Pathways
Maps:       
Reactions:
ESCHER  BiGG

Small Molecules
Ligands 1 Unique
ID Chains Name / Formula / InChI Key 2D Diagram 3D Interactions
2Q8
Query on 2Q8

A 4-(2,7,7-trimethyl-5-oxo-1,2,3,4,5,6,7,8- octahydro-9H-beta-carbolin-9-yl)benzamide
C21 H25 N3 O2
SMJJAAHWGIEVIU-UHFFFAOYSA-N
Ligand Explorer NGL
 
Binding Pocket (JSmol)
 
Electron Density (JSmol)
External Ligand Annotations
ID Binding Affinity (Sequence Identity %)
2Q8 Ki: 580 - 690 nM (92 - 100) BindingDB

Ki: 690 nM  BindingMOAD
N/A in PDBbind

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.82 Å
  • R-Value Free: 0.205
  • R-Value Work: 0.191
  • Space Group: I 2 2 2

Unit Cell:

Length (Å) Angle (°)
a = 67.19 α = 90.00
b = 90.92 β = 90.00
c = 99.06 γ = 90.00

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History

Deposition Data

  • Deposited Date: 2013-12-13
  • Released Date: 2014-12-24
  • Deposition author(s): Zuccola, H.J., Ernst, J.

Revision History

  • Version 1_0: 2014-12-24

    Type: Initial release